WaveMan · Form 4
Tingley Whittemore insider trades
> Search tickers & screens ⌘K
LIVE

Tingley Whittemore insider trades

Tingley Whittemore has filed 16 Form 4s with the SEC that we hold, all for Tenaya Therapeutics, Inc. (TNYA), as Chief Medical Officer. Across all of them we count 0 purchases worth $0 and 17 sales worth $103.0K reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($12.7K). The largest single trade was a sale of 6,500 shares of Tenaya Therapeutics, Inc. worth $38.1K, dated 2024-02-16. The first filing on our record is dated 2022-02-17 and the latest 2026-09-11.

Tenaya Therapeutics, Inc. (TNYA)

Chief Medical Officer · 16 filings · 17 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-08-16S, sale reported on Form 45,563$21.2K2023-08-18
2024-02-16S, sale reported on Form 46,500$38.1K2024-02-16
2024-08-16S, sale reported on Form 41,625$4.7K2024-08-16
2024-08-16S, sale reported on Form 45,803$16.8K2024-08-16
2025-03-10S, sale reported on Form 41,598$8632025-03-10
2025-03-10S, sale reported on Form 41,727$9332025-03-10
2025-03-10S, sale reported on Form 44,073$2.2K2025-03-10
2025-05-16S, sale reported on Form 42,937$1.3K2025-05-16
2025-08-18S, sale reported on Form 41,608$2.0K2025-08-18
2025-08-18S, sale reported on Form 41,837$2.3K2025-08-18
2025-11-17S, sale reported on Form 42,877$3.8K2025-11-17
2026-02-17S, sale reported on Form 41,642$1.1K2026-02-17
2026-02-17S, sale reported on Form 41,876$1.2K2026-02-17
2026-05-18S, sale reported on Form 43,121$2.5K2026-05-19
2026-08-17S, sale reported on Form 41,637$1.2K2026-08-17
2026-08-17S, sale reported on Form 41,871$1.3K2026-08-17
2026-08-17S, sale reported on Form 42,279$1.6K2026-08-17
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1868494) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms